Oligohydramnios is a condition that can develop during pregnancy. It occurs when not enough amniotic fluid, which surrounds the fetus, is produced.

Adverse perinatal outcomes associated with oligohydramnios are: umbilical cord compression; uteroplacental insufficiency, which is related to fetal growth restriction, pre-eclampsia, and other ...

However, its use in early midtrimester PPROM patients with severe oligohydramnios is reasonable based on the high mortality rate and underlying pathophysiology. References Geary C, Whitsett J .

Pulmonary hypoplasia is associated with reduced lung function in infancy. The aim of this study was to evaluate the hypothesis that children exposed to oligohydramnios display an increased risk of ...

Current evidence on the safety and efficacy of therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) does not appear adequate for this procedure to be used without special ...

Case Report. J. L. is a healthy, 20-year-old gravida 2 para 0010 at 41 and 0/7 weeks' gestation, based on the first day of her last menstrual period and first trimester ultrasound.

Evidence-based recommendations on therapeutic amnioinfusion for treating oligohydramnios during pregnancy (excluding labour). This involves injecting a substance similar to amniotic fluid into the ...